zur Startseite


Veranstalter, Ort

Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate Trial

Judith Trotman, Christian Buske, Alessandra Tedeschi, Jeffrey V Matous, David MacDonald, Constantine S Tam, Olivier Tournilhac, Shuo Ma, Steven P Treon, Albert Oriol, Jerry Ping, Eva M Briso, Israel Arango-Hisijara, Meletios A Dimopoulos
read more ›

Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström's Macroglobulinemia

Lisa Marie Kaiser, Mirja Harms, Daniel Sauter, Vijay P S Rawat, Mirco Glitscher, Eberhard Hildt, Daniel Tews, Zachary Hunter, Jan Münch, Christian Buske
read more ›



  • BNLI (R. Owen/UK)
  • Czech Myeloma Group (R. Hajek/Czech Republic)
  • FIL Italian Intergroup (A. Tedeschi/Italy)
  • FCGCLLWM Group (P. Morel, X. Leleu, V.LeBlond/France)
  • GLA/OSHO (C. Buske, M. Dreyling, M. Herold/Germany)    
  • Greek Myeloma Study Group (M. Dimopoulos, E. Kastritis/Greece)
  • HOVON (M.-J. Kersten/Netherlands)                                                            
  • Nordic Lymphoma Group (E. Kimby/Sweden)
  • Portuguese Lymphoma Study Group (M. Gomes da Silva/Portugal)
  • Spanish Study Group (R. Garcia Sanz/Spain)


In association with the "Australasian Leukaemia & Lymphoma Group" (ALLG).





Here you will find the communication platform of "European Consortium for Waldenstrom's Macroglobulinemia". Log in here with your user name and password. If you do not have access, you can get it by email via our contact form.